Clinical expression and new SPINK5 splicing defects in Netherton syndrome: unmasking a frequent founder synonymous mutation and unconventional intronic mutations.

[1]  G. Zambruno,et al.  Proteolytic activation cascade of the Netherton syndrome-defective protein, LEKTI, in the epidermis: implications for skin homeostasis. , 2011, The Journal of investigative dermatology.

[2]  V. Sybert.  Genetic Skin Disorders , 2010 .

[3]  P. Dubus,et al.  Elastase 2 is expressed in human and mouse epidermis and impairs skin barrier function in Netherton syndrome through filaggrin and lipid misprocessing. , 2010, The Journal of clinical investigation.

[4]  A. Hovnanian,et al.  ‘Matchstick’ eyebrow hairs: a dermoscopic clue to the diagnosis of Netherton syndrome , 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.

[5]  J. Orange,et al.  Comèl-Netherton syndrome defined as primary immunodeficiency. , 2009, The Journal of allergy and clinical immunology.

[6]  P. Dubus,et al.  Kallikrein 5 induces atopic dermatitis–like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome , 2009, The Journal of experimental medicine.

[7]  C. Béroud,et al.  Human Splicing Finder: an online bioinformatics tool to predict splicing signals , 2009, Nucleic acids research.

[8]  Yinmo Yang,et al.  SPINK5 gene mutation and decreased LEKTI activity in three Chinese patients with Netherton's syndrome , 2007, Clinical and experimental dermatology.

[9]  A. Hovnanian,et al.  LEKTI fragments specifically inhibit KLK5, KLK7, and KLK14 and control desquamation through a pH-dependent interaction. , 2007, Molecular biology of the cell.

[10]  Yu-Hung Wu,et al.  Netherton syndrome: mutation analysis of two Taiwanese families , 2007, Archives of Dermatological Research.

[11]  E. Diamandis,et al.  A Potential Role for Multiple Tissue Kallikrein Serine Proteases in Epidermal Desquamation* , 2006, Journal of Biological Chemistry.

[12]  P. Elias,et al.  Serine protease activity and residual LEKTI expression determine phenotype in Netherton syndrome. , 2006, The Journal of investigative dermatology.

[13]  U. Inserm.  Corneodesmosomal cadherins are preferential targets of stratum corneum trypsin-and chymotrypsin-like hyperactivity in Netherton syndrome , 2006 .

[14]  M. Walden,et al.  hK5 and hK7, two serine proteinases abundant in human skin, are inhibited by LEKTI domain 6 , 2005, The British journal of dermatology.

[15]  Y. Shimomura,et al.  Netherton syndrome in two Japanese siblings with a novel mutation in the SPINK5 gene: immunohistochemical studies of LEKTI and other epidermal molecules , 2005, The British journal of dermatology.

[16]  T. Shimizu,et al.  A Japanese infant with localized ichthyosis linearis circumflexa on the palms and soles harbouring a compound heterozygous mutation in the SPINK5 gene , 2005, The British journal of dermatology.

[17]  Peter K Rogan,et al.  Automated splicing mutation analysis by information theory , 2005, Human mutation.

[18]  A. Sonnenberg,et al.  Spink5-deficient mice mimic Netherton syndrome through degradation of desmoglein 1 by epidermal protease hyperactivity , 2005, Nature Genetics.

[19]  R. Callard,et al.  LEKTI demonstrable by immunohistochemistry of the skin: a potential diagnostic skin test for Netherton syndrome , 2004, The British journal of dermatology.

[20]  M. Raghunath,et al.  SPINK5 and Netherton syndrome: novel mutations, demonstration of missing LEKTI, and differential expression of transglutaminases. , 2004, The Journal of investigative dermatology.

[21]  C. Bodemer,et al.  LEKTI proteolytic processing in human primary keratinocytes, tissue distribution and defective expression in Netherton syndrome. , 2003, Human molecular genetics.

[22]  Jinhua Wang,et al.  ESEfinder: a web resource to identify exonic splicing enhancers , 2003, Nucleic Acids Res..

[23]  C. Bodemer,et al.  Prenatal diagnosis of a lethal form of Netherton syndrome by SPINK5 mutation analysis , 2002, Prenatal diagnosis.

[24]  C. Bodemer,et al.  Netherton syndrome: disease expression and spectrum of SPINK5 mutations in 21 families. , 2002, The Journal of investigative dermatology.

[25]  R. Silverman,et al.  The spectrum of pathogenic mutations in SPINK5 in 19 families with Netherton syndrome: implications for mutation detection and first case of prenatal diagnosis. , 2001, The Journal of investigative dermatology.

[26]  H. Savelkoul,et al.  Clinico-Immunological Heterogeneity in Comèl-Netherton Syndrome , 2001, Dermatology.

[27]  Sharon E. Albers,et al.  Textbook of Pediatric Dermatology , 2001 .

[28]  C. Bodemer,et al.  Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome , 2000, Nature Genetics.

[29]  I. Hausser,et al.  Severe Congenital Generalized Exfoliative Erythroderma in Newborns and Infants: A Possible Sign of Netherton Syndrome , 1996, Pediatric dermatology.

[30]  D. Smith,et al.  Netherton's syndrome , 1995, The British journal of dermatology.

[31]  J. Harper,et al.  A clinical and immunological study of Netherton's syndrome , 1994, The British journal of dermatology.

[32]  E. W. Netherton.  A unique case of trichorrhexis nodosa; bamboo hairs. , 1958, A.M.A. archives of dermatology.

[33]  M. Comèl.  Ichthyosis linearis circumflexa , 1949 .